NEUROCRINE BIOSCIENCES INC shareholders Q3 2023

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
BNP Paribas Asset Management Holding S.A. 3,100,000$4,6280.01%
Invesco Ltd. 23,914,000$35,476,4190.01%
AGF MANAGEMENT LTD 700,000$1,038,4500.01%
FIRST HAWAIIAN BANK 47,000$69,7250.00%
PUTNAM INVESTMENTS LLC 778,000$1,154,1630.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 10,000$14,9300.00%
Capital Analysts, LLC 2,000$30.00%
UBS Group AG 1,000$1,4840.00%
JANE STREET GROUP, LLC 259,000$393,0320.00%
ROYAL BANK OF CANADA 106,000$157,0000.00%

This page lists NEUROCRINE BIOSCIENCES INC's shareholders in Q3 2023. To view NEUROCRINE BIOSCIENCES INC's shareholder history, click here.